TickerFacts.

PAVmed Inc. (PAVM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$21.70M
Year ended 2025-12-31
-$26.62M
Trailing 12 months to 2026-06-30
2021-12-31: -$54.17M2022-12-31: -$88.63M2023-12-31: -$65.86M2024-12-31: -$43.29M2025-12-31: -$21.70M-$21.70M
2021-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$21.70Mn/m2026-03-27, From 2025-01-01
2024-12-31-$43.29Mn/m2026-03-27, From 2024-01-01
2023-12-31-$65.86Mn/m2025-03-24, From 2023-01-01
2022-12-31-$88.63Mn/m2024-03-25, From 2022-01-01
2021-12-31-$54.17Mn/a2023-03-14, From 2021-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
PAVmed Inc. (PAVM)2025-12-31-$21.70Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$5.92M+27.7%
Lucid Diagnostics Inc. (LUCD)2025-12-31-$48.77Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
Beyond Air, Inc. (XAIR)2026-03-31-$25.94Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$26.32Mn/m
Adagio Medical Holdings, Inc. (ADGM)2025-12-31-$20.92Mn/a
Cytosorbents Corp (CTSO)2025-12-31-$13.52Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$4.51M-46.4%

Compare PAVM, SNWV, LUCD, PREM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗